Publication | Closed Access

Ledipasvir plus sofosbuvir fixed-dose combination for 6 weeks in patients with acute hepatitis C virus genotype 1 monoinfection (HepNet Acute HCV IV): an open-label, single-arm, phase 2 study

HepatologyHepatitis CViral HepatitisAntiviral TherapyHepatitisVirologyChronic Viral InfectionAntiviral DrugMedicineEpidemiologySofosbuvir Fixed-dose Combination